Avid Bioservices to Participate at Upcoming Investor Conferences
02 September 2021 - 10:05PM
Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics
contract development and manufacturing organization (CDMO) working
to improve patient lives by providing high quality services to
biotechnology and pharmaceutical companies, today announced that
the company will participate in two upcoming investor conferences.
Details of the company’s participation are as
follows:
- Morgan Stanley
19th Annual Global Healthcare
ConferenceDetails: Avid management will participate in a
fireside chat and 1-on-1 meetingsConference Dates: September 9-10
and 13-15, 2021Fireside Chat Timing: 2:45 – 3:15 p.m. Eastern on
Thursday, September 9, 2021Format: Virtual conference; webcast
available
- HC Wainwright
23rd Annual Global Investment
ConferenceDetails: Avid management will deliver a
corporate presentation and participate in 1-on-1 meetingsConference
Dates: September 13-15, 2021Presentation Timing: Available online
at 7:00 a.m. Eastern on Monday, September 13, 2021Format: Virtual
conference
To listen to the live webcast of the Morgan
Stanley fireside chat, or access the archived webcast, please
visit: http://ir.avidbio.com/investor-events.
About Avid Bioservices,
Inc.Avid Bioservices is a dedicated contract
development and manufacturing organization (CDMO) focused on
development and CGMP manufacturing of biopharmaceutical drug
substances derived from mammalian cell culture. The company
provides a comprehensive range of process development, CGMP
clinical and commercial manufacturing services for the
biotechnology and biopharmaceutical industries. With 28 years of
experience producing monoclonal antibodies and recombinant
proteins, Avid's services include CGMP clinical and commercial drug
substance manufacturing, bulk packaging, release and stability
testing and regulatory submissions support. For early-stage
programs the company provides a variety of process development
activities, including upstream and downstream development and
optimization, analytical methods development, testing and
characterization. The scope of our services ranges from standalone
process development projects to full development and manufacturing
programs through commercialization. www.avidbio.com
Contacts:
Stephanie Diaz (Investors)
Vida Strategic Partners
415-675-7401
sdiaz@vidasp.com
Tim Brons (Media)
Vida Strategic Partners
415-675-7402
tbrons@vidasp.com
Avid Bioservices (NASDAQ:CDMOP)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Avid Bioservices (NASDAQ:CDMOP)
Historical Stock Chart
Von Jul 2023 bis Jul 2024